晚时间窗静脉溶栓在院间转运取栓前的应用
这项多中心回顾性队列研究纳入584例在大血管闭塞性急性缺血性卒中后超过4.5小时才到达初级卒中中心的患者,其中232例(39.7%)在转运至综合卒中中心前接受了静脉溶栓。经倾向评分重叠权重调整后,转运前静脉溶栓与3个月功能结局改善(PSOW-common OR 1.97;95% CI 1.33-2.92;P=.001)及转运期间再通率提高(PSOW-OR 8.69;95% CI 3.16-23.87;P<.001)独立相关,两组任何颅内出血和症状性颅内出血发生率相似。
要点
- 晚时间窗(>4.5小时)静脉溶栓在转运取栓前使用与3个月功能结局改善独立相关。
- 转运前静脉溶栓与转运期间再通率提高独立相关(PSOW-OR 8.69)。
- 两组任何颅内出血及症状性颅内出血发生率相似,未观察到安全信号。
核心结论
- 在超过4.5小时时间窗、拟转运至综合卒中中心行取栓的患者中,转运前启动静脉溶栓与转运期间再通率提高和3个月功能结局改善相关,且未增加出血风险。
研究设计与样本
- 纳入标准为超过最后正常时间4.5小时到达初级卒中中心、随后转运至综合卒中中心行取栓,转运前接受或未接受静脉溶栓。
- 采用倾向评分重叠权重平衡静脉溶栓组与未溶栓组的协变量。
主要发现
- 584例患者中309例(52.9%)为女性,中位年龄71(61-81)岁,基线NIHSS中位评分15(10-19)。
- 最后正常至初级卒中中心影像的中位时间为10.5(6.9-14.0)小时,232例(39.7%)在转运前接受静脉溶栓。
- 544例(93.2%)在初级卒中中心接受了高级脑影像(MRI或CT灌注)。
- 转运前静脉溶栓与3个月改良Rankin量表评分向更好方向偏移独立相关(PSOW-common OR 1.97;95% CI 1.33-2.92;P=.001)。
- 转运前静脉溶栓与转运期间再通率提高独立相关(PSOW-OR 8.69;95% CI 3.16-23.87;P<.001),两组任何颅内出血和症状性颅内出血发生率相似。
临床怎么用
- 对于超过4.5小时到达初级卒中中心、需转运至综合卒中中心取栓的大血管闭塞患者,可考虑在转运前启动静脉溶栓,以利用转运时间窗争取再通机会。
局限性
- 本研究为回顾性队列设计,存在残余混杂可能。
- 研究结论需前瞻性随机临床试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO), the benefit of intravenous thrombolysis (IVT) administered beyond 4.5 hours from the last time known well before endovascular therapy (EVT) is uncertain. Recently, the TIMELESS trial failed to demonstrate a benefit of IVT in this setting, but this trial focused on patients directly admitted to comprehensive stroke centers (CSCs) with fast access to EVT. OBJECTIVE: To assess the efficacy and safety of IVT initiated beyond 4.5 hours in patients with AIS-LVO initially admitted to primary stroke centers (PSCs) and subsequently transferred to a CSC for EVT, allowing substantial time for the IVT to take effect. DESIGN, SETTING, AND PARTICIPANTS: This multicenter retrospective cohort study was conducted between January 2020 and December 2024, with 3-month follow-up, at 20 French PSCs. All consecutive patients with AIS-LVO admitted beyond 4.5 hours from the last time they were known well in the PSC and subsequently transferred to a CSC for EVT, with or without IVT administered prior to transfer, were eligible for inclusion. Data analysis was performed between May 2025 and July 2025. MAIN OUTCOMES AND MEASURES: The primary outcome was the 3-month modified Rankin Scale score, analyzed in the ordinal approach. Propensity score with overlap weighting (PSOW) balanced covariates between patients treated with IVT vs those without. RESULTS: A total of 584 patients were included, among whom 309 patients (52.9%) were female. Median (IQR) age was 71 (61-81) years, median (IQR) baseline National Institutes of Health Stroke scale score was 15 (10-19), median (IQR) time from last known well to PSC imaging was 10.5 (6.9-14.0) hours, and 232 patients (39.7%) received IVT before transfer. Advanced brain imaging (magnetic resonance imaging or computed tomography [CT] with CT-perfusion) was performed at the PSC in 544 patients (93.2%). IVT use before transfer was independently associated with a shift toward better 3-month outcomes (PSOW-common odds ratio [OR], 1.97; 95% CI, 1.33-2.92; P = .001) and higher odds of recanalization during transfer (PSOW-OR, 8.69; 95% CI, 3.16-23.87; P < .001) compared with those without. The rate of any intracerebral hemorrhage and symptomatic intracerebral hemorrhage were similar between groups. CONCLUSIONS AND RELEVANCE: In this multicenter cohort study, IVT initiated beyond 4.5 hours prior to interhospital transfer for EVT was associated with higher rates of recanalization during transfer and improved 3-month functional outcomes, without safety concerns. These findings offer encouraging support for clinical trials evaluating IVT in the late time window before interhospital transfer.
引用
- Seners P, Nehme N, Ter Schiphorst A, et al. Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy. JAMA Neurol. 2026. PMID: 41324934. doi:10.1001/jamaneurol.2025.4712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。